Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Allarity Therapeutics (ALLR) Operating Margin (2024 - 2025)

Allarity Therapeutics' Operating Margin history spans 2 years, with the latest figure at 4945.76% for Q4 2025.

  • For Q4 2025, Operating Margin rose 2454043.0% year-over-year to 4945.76%; the TTM value through Dec 2025 reached 6813.51%, up 601290.0%, while the annual FY2025 figure was 3939.06%, N/A changed from the prior year.
  • Operating Margin reached 4945.76% in Q4 2025 per ALLR's latest filing, up from 4417.54% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 34441.67% in Q2 2025 to a low of 19594.67% in Q4 2024.